Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endologix, Inc reiterates FY 2014 guidance


Wednesday, 30 Apr 2014 04:01pm EDT 

Endologix, Inc:Reiterates FY 2014 financial guidance.Anticipates FY 2014 revenue to be in the range of $146 million to $152 million.Anticipates FY 2014 adjusted net loss per share of $(0.22) to $(0.35).Anticipates FY 2014 adjusted EBITDA per share of $(0.04) to $(0.17).FY 2014 revenue of $148 million and EPS of $(0.28) - Thomson Reuters I/B/E/S. 

Company Quote

11.48
0.16 +1.41%
4:00pm EDT